| J9271 | Injection, pembrolizumab, 1 mg | 10,800 | $40 | $453.6K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 2,530 | $30 | $83.3K |
| J0897 | Injection, denosumab, 1 mg | 3,540 | $20 | $63.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 350 | $90 | $31.7K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 4,960 | $10 | $29.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 330 | $90 | $28.4K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 150 | $90 | $12.6K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 90 | $130 | $12K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 70 | $130 | $9.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 9,750 | $1 | $9.8K |